Dean Eliott

Director at X1 Biotech.

Raised on X1 Biotech filings

$40K

of $2M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Jun 15, 2026

Company

Biotech · Needham, MA

RUNX1 inhibitor for inherited small-vessel brain disease

RUNX1 inhibitor for inherited small-vessel brain disease

Investors: 2
Still open: $2M

Investors: 2
Sector: Biotech
HQ: Needham, MA

X1 Biotech filings

X1 Biotech Form D filings
Filed	Security	Sold of offered	Filing
Jun 15, 2026	Security to be acquired	$40K/ $2M	Form D

Security to be acquiredFiled Jun 15, 2026Form D
$40K/ $2M

Works with

Also named on X1 Biotech filings

Lawrence KaufmanPresident and CEO, Form D signerForm D signer Michael AcetiExecutive Officer Joseph Arboleda-VelasquezDirector Leo KimDirector Neal ChenDirector